Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2001 Mar;85(3):277–280. doi: 10.1136/bjo.85.3.277

Persistence of acanthamoeba antigen following acanthamoeba keratitis

Y Yang 1, M Matheson 1, J Dart 1, I Cree 1
PMCID: PMC1723905  PMID: 11222330

Abstract

AIM—To investigate the hypothesis that persistent corneal and scleral inflammation following acanthamoeba keratitis is not always caused by active amoebic infection but can be due to persisting acanthamoebic antigens
METHODS—24 lamellar corneal biopsy and penetrating keratoplasty specimens were obtained from 14 consecutive patients at various stages of their disease and divided for microscopy and culture. Histological sections were immunostained and screened for the presence of Acanthamoeba cysts by light microscopy. Cultures were carried out using partly homogenised tissues on non-nutrient agar seeded with E coli. Clinical data were obtained retrospectively from the case notes of these patients.
RESULTS—Of the 24 specimens, 20 were obtained from eyes that were clinically inflamed at the time of surgery. Acanthamoeba cysts were present in 16 (80%) of these 20 specimens, while only five (25%) were culture positive. Acanthamoeba cysts were found to persist for up to 31 months after antiamoebic treatment.
CONCLUSION—These findings support the hypothesis that Acanthamoeba cysts can remain in corneal tissue for an extended period of time following acanthamoeba keratitis and may cause persistent corneal and scleral inflammation in the absence of active amoebic infection. In view of these findings, prolonged intensive antiamoebic therapy may be inappropriate when the inflammation is due to retained antigen rather than to viable organisms



Full Text

The Full Text of this article is available as a PDF (106.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auran J. D., Starr M. B., Jakobiec F. A. Acanthamoeba keratitis. A review of the literature. Cornea. 1987;6(1):2–26. [PubMed] [Google Scholar]
  2. Bacon A. S., Frazer D. G., Dart J. K., Matheson M., Ficker L. A., Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye (Lond) 1993;7(Pt 6):719–725. doi: 10.1038/eye.1993.168. [DOI] [PubMed] [Google Scholar]
  3. Blackman H. J., Rao N. A., Lemp M. A., Visvesvara G. S. Acanthamoeba keratitis successfully treated with penetrating keratoplasty: suggested immunogenic mechanisms of action. Cornea. 1984;3(2):125–130. [PubMed] [Google Scholar]
  4. Dana M. R., Streilein J. W. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci. 1996 Nov;37(12):2485–2494. [PubMed] [Google Scholar]
  5. Duguid I. G., Dart J. K., Morlet N., Allan B. D., Matheson M., Ficker L., Tuft S. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology. 1997 Oct;104(10):1587–1592. doi: 10.1016/s0161-6420(97)30092-x. [DOI] [PubMed] [Google Scholar]
  6. Garner A. Pathogenesis of acanthamoebic keratitis: hypothesis based on a histological analysis of 30 cases. Br J Ophthalmol. 1993 Jun;77(6):366–370. doi: 10.1136/bjo.77.6.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Holland E. J., Alul I. H., Meisler D. M., Epstein R. J., Rotkis W. M., Nathenson A. L., Liesegang T. J. Subepithelial infiltrates in Acanthamoeba keratitis. Am J Ophthalmol. 1991 Oct 15;112(4):414–418. doi: 10.1016/s0002-9394(14)76250-6. [DOI] [PubMed] [Google Scholar]
  8. Jones D. B., Visvesvara G. S., Robinson N. M. Acanthamoeba polyphaga keratitis and Acenthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc U K. 1975 Jul;95(2):221–232. [PubMed] [Google Scholar]
  9. Kremer I., Cohen E. J., Eagle R. C., Jr, Udell I., Laibson P. R. Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J. 1994 Jan;20(1):45–48. [PubMed] [Google Scholar]
  10. Lindquist T. D., Fritsche T. R., Grutzmacher R. D. Scleral ectasia secondary to Acanthamoeba keratitis. Cornea. 1990 Jan;9(1):74–76. [PubMed] [Google Scholar]
  11. Mannis M. J., Tamaru R., Roth A. M., Burns M., Thirkill C. Acanthamoeba sclerokeratitis. Determining diagnostic criteria. Arch Ophthalmol. 1986 Sep;104(9):1313–1317. doi: 10.1001/archopht.1986.01050210067027. [DOI] [PubMed] [Google Scholar]
  12. Mathers W., Stevens G., Jr, Rodrigues M., Chan C. C., Gold J., Visvesvara G. S., Lemp M. A., Zimmerman L. E. Immunopathology and electron microscopy of Acanthamoeba keratitis. Am J Ophthalmol. 1987 May 15;103(5):626–635. doi: 10.1016/s0002-9394(14)74321-1. [DOI] [PubMed] [Google Scholar]
  13. Streilein J. W. Regulation of ocular immune responses. Eye (Lond) 1997;11(Pt 2):171–175. doi: 10.1038/eye.1997.47. [DOI] [PubMed] [Google Scholar]
  14. Wright P., Warhurst D., Jones B. R. Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol. 1985 Oct;69(10):778–782. doi: 10.1136/bjo.69.10.778. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES